Lee Jennifer Kayden sold RYTM
February 1, 2026 · Form 4 insider transaction
Lee Jennifer Kayden sold 3,437 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,437
Price
$0.00
Total value
N/A
InsiderLee Jennifer Kayden
Role—
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateFebruary 1, 2026
Filing dateFebruary 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.; The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date.